SB3507 amends the Illinois Controlled Substances Act to require prescribers to access patient information in the Prescription Monitoring Program for.
SB3507 amends the Illinois Controlled Substances Act by requiring prescribers to document an attempt to access patient information in the Prescription Monitoring Program when providing a subsequent prescription for Schedule II and IV controlled substances. This requirement does not apply to initial prescriptions for oncology treatment, palliative care, or 7-day or less supplies provided by a hospital emergency department for acute, traumatic conditions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.